Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
RecombinantRabMAb

Recombinant Anti-TSG101 antibody [EPR7131(B)] (ab133586)

Submit a review Submit a question References (21)
Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
  • Immunoprecipitation - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
  • Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
  • OI-RD Scanning - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
  • Anti-TSG101 antibody [EPR7131(B)] (ab133586)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR7131(B)] to TSG101
  • Suitable for: WB, IP
  • Reacts with: Mouse, Rat, Human

Conjugates logo Related conjugates and formulations

Carrier Free

Overview

  • Product name

    Anti-TSG101 antibody [EPR7131(B)]
    See all TSG101 primary antibodies

  • Description

    Rabbit monoclonal [EPR7131(B)] to TSG101

  • Host species

    Rabbit

  • Tested applications

    Suitable for: WB, IPmore details
    Unsuitable for: ICC/IF or IHC-P

  • Species reactivity

    Reacts with: Mouse, Rat, Human

  • Immunogen

    Synthetic peptide within Human TSG101 (C terminal). The exact sequence is proprietary.
    Database link: Q99816

  • Positive control

    • WB: PC12, NIH 3T3, K562, 293T and Jurkat whole cell lysate (ab7899). IP: K562 whole cell lysate.

  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

    We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

Properties

Applications

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab133586 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
1/1000 - 1/10000. Predicted molecular weight: 44 kDa.
IP
1/10 - 1/100.
Notes
WB
1/1000 - 1/10000. Predicted molecular weight: 44 kDa.
IP
1/10 - 1/100.
Application notes
Is unsuitable for ICC/IF or IHC-P.

Target

  • Function

    Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Mediates the association between the ESCRT-0 and ESCRT-I complex. Required for completion of cytokinesis; the function requires CEP55. May be involved in cell growth and differentiation. Acts as a negative growth regulator. Involved in the budding of many viruses through an interaction with viral proteins that contain a late-budding motif P-[ST]-A-P. This interaction is essential for viral particle budding of numerous retroviruses.

  • Tissue specificity

    Heart, brain, placenta, lung, liver, skeletal, kidney and pancreas.

  • Sequence similarities

    Belongs to the ubiquitin-conjugating enzyme family. UEV subfamily.
    Contains 1 SB (steadiness box) domain.
    Contains 1 UEV (ubiquitin E2 variant) domain.

  • Domain

    The UEV domain is required for the interaction of the complex with ubiquitin. It also mediates the interaction with PTAP/PSAP motifs of HIV-1 P6 protein and human spumaretrovirus Gag protein.
    The coiled coil domain may interact with stathmin.
    The UEV domain binds ubiquitin and P-[ST]-A-P peptide motif independently.

  • Post-translational
    modifications

    Monoubiquitinated at multiple sites by LRSAM1 and by MGRN1. Ubiquitination inactivates it, possibly by regulating its shuttling between an active membrane-bound protein and an inactive soluble form. Ubiquitination by MGRN1 requires the presence of UBE2D1.

  • Cellular localization

    Cytoplasm. Membrane. Nucleus. Late endosome membrane. Mainly cytoplasmic. Membrane-associated when active and soluble when inactive. Depending on the stage of the cell cycle, detected in the nucleus. Colocalized with CEP55 in the midbody during cytokinesis.
  • Information by UniProt

  • Database links

    see all

  • Alternative names

    • ESCRT I complex subunit TSG101 antibody
    • ESCRT-I complex subunit TSG101 antibody
    • TS101_HUMAN antibody
    • TSG 10 antibody
    • TSG 101 antibody
    • TSG10 antibody
    • Tsg101 antibody
    • Tumor susceptibility 101 antibody
    • Tumor susceptibility gene 10 antibody
    • Tumor susceptibility gene 101 antibody
    • Tumor susceptibility gene 101 protein antibody
    • Tumor susceptibility protein antibody
    • Tumor susceptibility protein isoform 3 antibody
    • VPS 23 antibody
    • VPS23 antibody
    see all

Images

  • Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    All lanes : Anti-TSG101 antibody [EPR7131(B)] (ab133586) at 1/2000 dilution (purified)

    Lane 1 : K562 whole cell lysate
    Lane 2 : Jurkat whole cell lysate
    Lane 3 : PC-12 whole cell lysate
    Lane 4 : NIH/3T3 whole cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

    Predicted band size: 44 kDa
    Observed band size: 44 kDa



    Blocking/Diluting buffer 5% NFDM/TBST
  • Immunoprecipitation - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    Immunoprecipitation - Anti-TSG101 antibody [EPR7131(B)] (ab133586)

    ab133586 at 1/40 immunoprecipitating TSG101 in K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate observed at 44 KDa (lanes 1 and 2).

    Lane 1 (input): K562 whole cell lysate 10μg

    Lane 2 (+): ab133586 + K562 whole cell lysate.

    Lane 3 (-): Rabbit monoclonal IgG (ab172730) instead of ab133586 in whole cell lysate

    For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1000 dilution.

    Blocking buffer and concentration: 5% NFDM/TBST.
    Diluting buffer and concentration: 5% NFDM /TBST.

  • Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    Western blot - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    All lanes : Anti-TSG101 antibody [EPR7131(B)] (ab133586) at 1/1000 dilution (unpurified)

    Lane 1 : PC12 cell lysate
    Lane 2 : NIH 3T3 cell lysate
    Lane 3 : 293T cell lysate
    Lane 4 : Jurkat cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution

    Predicted band size: 44 kDa



    Note: Dilute primary antibody in 1% BSA.
  • OI-RD Scanning - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    OI-RD Scanning - Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    Equilibrium disassociation constant (KD)
    Learn more about KD

    Click here to learn more about KD
  • Anti-TSG101 antibody [EPR7131(B)] (ab133586)
    Anti-TSG101 antibody [EPR7131(B)] (ab133586)

References (21)

Publishing research using ab133586? Please let us know so that we can cite the reference in this datasheet.

ab133586 has been referenced in 21 publications.

  • Dong L  et al. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther 12:4 (2021). PubMed: 33407872
  • Fang X  et al. A magnetic bead-mediated selective adsorption strategy for extracellular vesicle separation and purification. Acta Biomater 124:336-347 (2021). PubMed: 33578055
  • Li D  et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6. Stem Cell Res Ther 12:24 (2021). PubMed: 33413548
  • Huang Y  et al. EPC-Derived Exosomal miR-1246 and miR-1290 Regulate Phenotypic Changes of Fibroblasts to Endothelial Cells to Exert Protective Effects on Myocardial Infarction by Targeting ELF5 and SP1. Front Cell Dev Biol 9:647763 (2021). PubMed: 34055778
  • Feng Y  et al. The Role and Underlying Mechanism of Exosomal CA1 in Chemotherapy Resistance in Diffuse Large B Cell Lymphoma. Mol Ther Nucleic Acids 21:452-463 (2020). PubMed: 32668392
View all Publications for this product

Customer reviews and Q&As

Show All Reviews Q&A
Submit a review Submit a question

There are currently no Customer reviews or Questions for ab133586.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com